These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26086136)

  • 1. How many memories does it take to make an SLE flare?
    Tarlinton DM; Smith KG
    Nat Immunol; 2015 Jul; 16(7):685-7. PubMed ID: 26086136
    [No Abstract]   [Full Text] [Related]  

  • 2. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus.
    Tipton CM; Fucile CF; Darce J; Chida A; Ichikawa T; Gregoretti I; Schieferl S; Hom J; Jenks S; Feldman RJ; Mehr R; Wei C; Lee FE; Cheung WC; Rosenberg AF; Sanz I
    Nat Immunol; 2015 Jul; 16(7):755-65. PubMed ID: 26006014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
    Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
    Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function and significance of B-lymphocyte defects in the pathogenesis of systemic lupus erythematosus].
    Wollina U
    Dermatol Monatsschr; 1984; 170(2):81-90. PubMed ID: 6202566
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
    Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
    Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
    Yaniv G; Twig G; Shor DB; Furer A; Sherer Y; Mozes O; Komisar O; Slonimsky E; Klang E; Lotan E; Welt M; Marai I; Shina A; Amital H; Shoenfeld Y
    Autoimmun Rev; 2015 Jan; 14(1):75-9. PubMed ID: 25449682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a nested case-control study.
    Fatemi A; Samadi G; Sayedbonakdar Z; Smiley A
    Mod Rheumatol; 2016; 26(2):233-9. PubMed ID: 26357965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How long does it take to describe 25 SLE antigen/antibody systems?
    Alarcón-Segovia D
    Lupus; 1999; 8(4):332. PubMed ID: 10413215
    [No Abstract]   [Full Text] [Related]  

  • 13. Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice.
    Slack JH; Hang L; Barkley J; Fulton RJ; D'Hoostelaere L; Robinson A; Dixon FJ
    J Immunol; 1984 Mar; 132(3):1271-5. PubMed ID: 6537961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can killers be saviors?
    Singh G; Agarwal AK; Prosek J; Jayadev MSK; Singh A
    Lupus; 2017 Aug; 26(9):903-908. PubMed ID: 28121242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of monocyte reactive antibodies on monocyte chemotaxis in systemic lupus erythematosus.
    Szegedi G; Lukács K; Bodolay E; Gulácsi L; Sonkoly I; Szabó G; Szöllösi J
    Haematologia (Budap); 1985; 18(3):175-83. PubMed ID: 3836156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
    Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antibody profile of systemic lupus erythematosus detected by antigen microarray.
    Fattal I; Shental N; Mevorach D; Anaya JM; Livneh A; Langevitz P; Zandman-Goddard G; Pauzner R; Lerner M; Blank M; Hincapie ME; Gafter U; Naparstek Y; Shoenfeld Y; Domany E; Cohen IR
    Immunology; 2010 Jul; 130(3):337-43. PubMed ID: 20201986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipneumococcal vaccination in patient with systemic lupus erythematosus].
    Pisoni C; Sarano J; Benchetrit G; Rodríguez D; Suárez L; Perrota C; Manni J
    Medicina (B Aires); 2003; 63(5):388-92. PubMed ID: 14628647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.